cro.directory
← Compare landing

NEPHRIX Biosolutions vs Scantox

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryNEPHRIX BiosolutionsScantox
SummarySpecialized preclinical CRO offering in vitro and in vivo kidney disease models, histology services, and biomarker analysis for renal and fibrotic disease drug development.Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity.
Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Pathology & Histology Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Rare Disease
  • Nephrology
  • Neurology
  • Psychiatry
Phases
  • Preclinical (General)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Labège, Occitanie, France
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

NEPHRIX Biosolutions alternatives · Scantox alternatives

Markdown mirror: /compare/nephrix-biosolutions/scantox.md